PoC testing is in the market today – it is worth approximately US$11.5 billion annually, with percentage growth in double figures and some three-times faster than the total IVD market. Applications to ...

In a study published today in Biofunctional Materials, Prof. Dr. Haidar, Founder and CEO of BioMAT’X I+D+I LABs in Santiago, Chile, explores a new era in healthcare diagnostics driven by ...

We discuss here critical factors in ensuring the success of a viral diagnostic at the point of care. Molecular and immunoassay approaches are reviewed with a focus on their ability to meet the ...

The point of care molecular (POC) diagnostics market is poised for robust growth on the back of the burgeoning prevalence of infectious diseases across the globe. As per the CDC (Centers for Disease ...

The MarketWatch News Department was not involved in the creation of this content. The Point-of-Care Diagnostics market is driven by the increasing demand for rapid and accurate testing solutions, ...

Abbott Laboratories holds a leadership position in the point of care diagnostics market through its diverse range of products including glucose monitoring devices, infectious disease diagnostic tools, ...

Lateral flow assays, also called immunochromatographic assays, identify or measure biomolecules in intricate samples like blood, saliva, urine, or other fluids to diagnose numerous medical conditions.